- Moderna Inc (NASDAQ: MRNA) has agreed to supply the Philippines government with 13 million doses of its COVID-19 vaccine.
- Deliveries are set to begin in mid-2021.
- The company's COVID-19 vaccine is not currently approved for use in the country, and it will work with regulators to pursue necessary approvals before distribution.
- The company also anticipates a separate deal with the Philippines government and private sector to supply an additional 7 million doses.
- The Philippines regulator has so far approved for emergency use COVID-19 vaccines developed by Pfizer Inc (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX), AstraZeneca Plc (NASDAQ: AZN), and Sinovac Biotech (NASDAQ: SVA).
- Price Action: MRNA shares are down 2.4% at $129.01 in premarket trading on the last check Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in